0
CTI BioPharma Corp
- 201-500 Employees
- Based in Seattle, Washington
CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione derivative for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell…More
CTI BioPharma Corp
Most Recent Annual Report
CTI BioPharma Corp does not currently have any hardcopy reports on ²©¾ÅÓéÀÖÍø. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
